The moniker was coined back in November 2021, when the same team introduced an injection of these molecules to repair tissues and reverse paralysis after severe spinal cord injuries in mice.
Now they've applied the same therapeutic strategy to damaged human cartilage cells. According to a study published by the Journal of the American Chemical Society, the treatment activated the gene expression necessary to regenerate cartilage within just four hours.